|
GB1432562A
(en)
*
|
1972-04-10 |
1976-04-22 |
Rustenburg Platinum Mines Ltd |
Platinum co-ordination compounds
|
|
US4329299A
(en)
*
|
1979-08-23 |
1982-05-11 |
Johnson, Matthey & Co., Limited |
Composition of matter containing platinum
|
|
US4302446A
(en)
*
|
1979-10-02 |
1981-11-24 |
Bristol-Myers Company |
Pharmaceutical compositions
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
EP0167310B1
(en)
*
|
1984-06-27 |
1991-05-29 |
Johnson Matthey Public Limited Company |
Platinum co-ordination compounds
|
|
US5082655A
(en)
*
|
1984-07-23 |
1992-01-21 |
Zetachron, Inc. |
Pharmaceutical composition for drugs subject to supercooling
|
|
CA1327039C
(en)
*
|
1986-12-18 |
1994-02-15 |
Tetsushi Totani |
Ammine-alicyclic amine-platinum complexes and antitumor agents
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
GB9105037D0
(en)
*
|
1991-03-09 |
1991-04-24 |
Johnson Matthey Plc |
Improvements in chemical compounds
|
|
US5244991A
(en)
*
|
1991-10-15 |
1993-09-14 |
Phillips Petroleum Company |
Olefin polymerization process
|
|
ATE247471T1
(de)
*
|
1991-11-15 |
2003-09-15 |
Smithkline Beecham Corp |
Cisplatin und topotecan enthaltende zusammensetzung als antitumor.
|
|
JP3633932B2
(ja)
*
|
1992-04-01 |
2005-03-30 |
ザ ジョーンズ ホプキンズ ユニバーシティー スクール オブ メディシン |
糞便試料から単離した哺乳類の核酸を検出する方法、およびその検出用試薬
|
|
US5624919A
(en)
*
|
1993-09-14 |
1997-04-29 |
The University Of Vermont And State Agricultural College |
Trans platinum (IV) complexes
|
|
GB9408218D0
(en)
*
|
1994-04-26 |
1994-06-15 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
|
AU2768295A
(en)
*
|
1994-07-11 |
1996-02-09 |
Hoechst Marion Roussel, Inc. |
Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
|
|
US5626862A
(en)
*
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5789000A
(en)
*
|
1994-11-14 |
1998-08-04 |
Bionumerik Pharmaceuticals, Inc. |
Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
|
|
US5919816A
(en)
*
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
GB9502799D0
(en)
*
|
1995-02-14 |
1995-04-05 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
|
US6245349B1
(en)
*
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
|
US6441025B2
(en)
*
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
|
WO1997049411A1
(en)
*
|
1996-06-25 |
1997-12-31 |
Glaxo Group Limited |
Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
|
|
DE19847618A1
(de)
*
|
1998-10-15 |
2000-04-20 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
|
US6235782B1
(en)
*
|
1998-11-12 |
2001-05-22 |
Rifat Pamukcu |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
|
|
US6413953B1
(en)
*
|
1999-04-13 |
2002-07-02 |
Anormed Inc. |
Pt(IV) antitumor agent
|
|
CN1916009B
(zh)
*
|
1999-04-13 |
2010-12-15 |
阿诺麦德股份有限公司 |
制备胺铂配合物的方法
|
|
GB9925127D0
(en)
*
|
1999-10-22 |
1999-12-22 |
Pharmacia & Upjohn Spa |
Oral formulations for anti-tumor compounds
|
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
|
HUP0204139A3
(en)
*
|
2000-02-16 |
2003-07-28 |
Yamanouchi Pharma Co Ltd |
Use of n-[6-methoxi-5-(2-methoxiphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2phenyl-etienesulfonamide for producing pharmaceutical composition using for reducing pain in an endothelin-induced disease
|
|
US20030027808A1
(en)
*
|
2000-02-29 |
2003-02-06 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
US20020156033A1
(en)
*
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
US6545010B2
(en)
*
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
|
US20020110601A1
(en)
*
|
2000-03-31 |
2002-08-15 |
Roman Perez-Soler |
Antineoplastic platinum therapeutic method and composition
|
|
EE200200565A
(et)
*
|
2000-03-31 |
2004-06-15 |
Angiogene Pharmaceuticals Ltd. |
Vaskulaarse kahjustava toimega kombinatsioonravi
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US7253209B2
(en)
*
|
2000-08-11 |
2007-08-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Remedies for cisplatin-tolerant cancer
|
|
US6894049B1
(en)
*
|
2000-10-04 |
2005-05-17 |
Anormed, Inc. |
Platinum complexes as antitumor agents
|
|
US6544962B1
(en)
*
|
2000-11-02 |
2003-04-08 |
Matrix Pharmaceutical, Inc. |
Methods for treating cellular proliferative disorders
|
|
SE0004671D0
(sv)
*
|
2000-12-15 |
2000-12-15 |
Amarin Dev Ab |
Pharmaceutical formulation
|
|
EP2289508A1
(en)
*
|
2001-01-30 |
2011-03-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
Combined treatment for lung cancer
|
|
AR035227A1
(es)
*
|
2001-02-20 |
2004-05-05 |
Oncolytics Biotech Inc |
Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
|
|
US6673370B2
(en)
*
|
2001-05-15 |
2004-01-06 |
Biomedicines, Inc. |
Oxidized collagen formulations for use with non-compatible pharmaceutical agents
|
|
IL160103A0
(en)
*
|
2001-08-06 |
2004-06-20 |
Astrazeneca Ab |
Aqueous dispersion comprising stable nanoparticles of a water-insoluble active substance and an excipient like middle chain triglycerides (mct)
|
|
CA2456746A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Method for treating lung cancers
|
|
DE10141528B4
(de)
*
|
2001-08-24 |
2006-08-10 |
Faustus Forschungs Cie. Translational Cancer Research Gmbh |
Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
|
|
US20030144312A1
(en)
*
|
2001-10-30 |
2003-07-31 |
Schoenhard Grant L. |
Inhibitors of ABC drug transporters in multidrug resistant cancer cells
|
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
|
US20050119238A1
(en)
*
|
2002-03-01 |
2005-06-02 |
Baron John A. |
Compositions and methods for preventing sporadic neoplasia in colon
|
|
WO2003077932A1
(en)
*
|
2002-03-18 |
2003-09-25 |
Sumitomo Pharmaceuticals Co., Ltd. |
Remedies for lung cancer
|
|
US20040010553A1
(en)
*
|
2002-07-15 |
2004-01-15 |
International Business Machines Corporation |
Peer to peer location based services
|
|
AU2003251955A1
(en)
*
|
2002-07-16 |
2004-02-02 |
Sonus Pharmaceuticals, Inc. |
Platinum compound
|
|
EP1545459A4
(en)
*
|
2002-08-02 |
2007-08-22 |
Transave Inc |
PLATINUM AGGREGATES, AND METHOD FOR MANUFACTURING THE SAME
|
|
US20040156816A1
(en)
*
|
2002-08-06 |
2004-08-12 |
David Anderson |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
AU2002951833A0
(en)
*
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
US8217010B2
(en)
*
|
2002-10-24 |
2012-07-10 |
The Board Of Trustees Of The University Of Illinois |
Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
|
|
TWI323662B
(en)
*
|
2002-11-15 |
2010-04-21 |
Telik Inc |
Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
|
|
DE10256182A1
(de)
*
|
2002-12-02 |
2004-06-24 |
Merck Patent Gmbh |
2-Oxadiazolchromonderivate
|
|
US7109337B2
(en)
*
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
ATE389650T1
(de)
*
|
2003-04-30 |
2008-04-15 |
Merck Patent Gmbh |
Chromenonderivate
|
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
|
US20070065522A1
(en)
*
|
2004-03-18 |
2007-03-22 |
Transave, Inc. |
Administration of high potency platinum compound formulations by inhalation
|
|
JP2007537238A
(ja)
*
|
2004-05-14 |
2007-12-20 |
ファイザー・プロダクツ・インク |
異常細胞増殖の治療のためのピリミジン誘導体
|
|
MXPA06011658A
(es)
*
|
2004-05-14 |
2006-12-14 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
|
|
TW200538149A
(en)
*
|
2004-05-20 |
2005-12-01 |
Telik Inc |
Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
|
|
TW200600091A
(en)
*
|
2004-05-21 |
2006-01-01 |
Telik Inc |
Sulfonylethyl phosphorodiamidates
|
|
US7378423B2
(en)
*
|
2004-06-11 |
2008-05-27 |
Japan Tobacco Inc. |
Pyrimidine compound and medical use thereof
|
|
EP2298291A3
(en)
*
|
2004-06-18 |
2011-08-03 |
Agennix USA Inc. |
Kinase inhibitors for treating cancers
|
|
US20060003950A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Bone Care International, Inc. |
Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
|
|
US20060058311A1
(en)
*
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
CN101039927A
(zh)
*
|
2004-09-09 |
2007-09-19 |
财团法人乙卯研究所 |
5－羟色胺5－ht3受体激动剂
|
|
MX2007003314A
(es)
*
|
2004-09-22 |
2007-08-06 |
Pfizer |
Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas.
|
|
US20060205810A1
(en)
*
|
2004-11-24 |
2006-09-14 |
Schering Corporation |
Platinum therapeutic combinations
|
|
US7807662B2
(en)
*
|
2004-12-23 |
2010-10-05 |
University Of South Florida |
Platinum IV complex inhibitor
|
|
JP5106098B2
(ja)
*
|
2005-02-28 |
2012-12-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホンアミド化合物の抗癌剤との新規併用
|
|
WO2006104668A2
(en)
*
|
2005-03-11 |
2006-10-05 |
Temple University - Of The Commonwealth System Of Higher Education |
Composition and methods for the treatment of proliferative diseases
|
|
JP2006319399A
(ja)
*
|
2005-05-10 |
2006-11-24 |
Nec Electronics Corp |
パルス幅変調回路及び多相クロック生成回路
|
|
PL1888550T3
(pl)
*
|
2005-05-12 |
2014-12-31 |
Abbvie Bahamas Ltd |
Promotory apoptozy
|
|
EP3527202A1
(en)
*
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
US20070190181A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
|
|
US20070190182A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
WO2007056263A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
EP1792622A1
(en)
*
|
2005-11-11 |
2007-06-06 |
GPC Biotech AG |
Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
|
|
US8158152B2
(en)
*
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
WO2007064658A2
(en)
*
|
2005-11-30 |
2007-06-07 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
US8143236B2
(en)
*
|
2005-12-13 |
2012-03-27 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods
|
|
WO2007109184A2
(en)
*
|
2006-03-16 |
2007-09-27 |
Bionumerik Pharmaceuticals, Inc. |
Anti-cancer activity augmentation compounds and formulations and methods of use thereof
|
|
US8168662B1
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
MX2009008487A
(es)
*
|
2007-02-09 |
2010-01-15 |
Poniard Pharmaceuticals Inc |
Picoplatino encapsulado.
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
CA2689033A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Ascenta Therapeutics, Inc. |
Pulsatile dosing of gossypol for treatment of disease
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
US20100310661A1
(en)
*
|
2007-07-16 |
2010-12-09 |
Poniard Pharmaceuticals, Inc. |
Oral formulations for picoplatin
|
|
EP2436376B1
(en)
*
|
2007-09-28 |
2014-07-09 |
BIND Therapeutics, Inc. |
Cancer cell targeting using nanoparticles
|
|
CA2715348A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
|
US20110025581A1
(en)
*
|
2009-07-31 |
2011-02-03 |
David John Geer |
Antenna assembly
|